R 637 Pill - gray capsule/oblong, 19mm
Pill with imprint R 637 is Gray, Capsule/Oblong and has been identified as Gabapentin 800 mg. It is supplied by Actavis.
Gabapentin is used in the treatment of Back Pain; Postherpetic Neuralgia; Epilepsy; Chronic Pain; Seizures and belongs to the drug class gamma-aminobutyric acid analogs. Risk cannot be ruled out during pregnancy. Gabapentin 800 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for R 637
Gabapentin
- Imprint
- R 637
- Strength
- 800 mg
- Color
- Gray
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Gamma-aminobutyric acid analogs
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis
- Inactive Ingredients
-
calcium stearate,
crospovidone,
hydroxypropyl cellulose,
polyethylene glycol 400,
titanium dioxide,
ferrosoferric oxide,
polyethylene glycol 8000
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00228-2637 | Actavis Pharma, Inc. |
68084-0625 (Discontinued) | Amerisource Health Services |
52959-0772 | H.J. Harkins Company, Inc. (repackager) |
49999-0799 (Discontinued) | Lake Erie Medical and Surgical Supply (repackager) |
63874-1129 (Discontinued) | Altura Pharmaceuticals Inc. (repackager) |
Related images for "R 637"
More about gabapentin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2,541)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: gamma-aminobutyric acid analogs
- Breastfeeding
- En español
Patient resources
- Gabapentin drug information
- Gabapentin Capsules
- Gabapentin Oral Solution
- Gabapentin Tablets (PHN)
- Gabapentin Tablets 600 mg and 800 mg
Other brands
Professional resources
- Gabapentin monograph
- Gabapentin (FDA)
- Gabapentin Capsules (FDA)
- Gabapentin Oral Solution (FDA)
- Gabapentin Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.